99精品久久这里只有精品,三上悠亚免费一区二区在线,91精品福利一区二区,爱a久久片,无国产精品白浆免费视,中文字幕欧美一区,爽妇网国产精品,国产一级做a爱免费观看,午夜一级在线,国产精品偷伦视频免费手机播放

400-888-7502 登錄/注冊購物車(0)

期刊導(dǎo)航

首頁 > SCI期刊 > 醫(yī)學(xué)期刊 > Jnci-journal Of The National Cancer Institute(非官網(wǎng))

收藏該雜志

同大類學(xué)科其它級(jí)別期刊：

中科院 1區(qū) 期刊 JCR Q1 期刊中科院 2區(qū) 期刊 JCR Q2 期刊中科院 3區(qū) 期刊 JCR Q3 期刊中科院 4區(qū) 期刊 JCR Q4 期刊

Jnci-journal Of The National Cancer Institute SCIE

國際簡稱：J NATL CANCER I 參考譯名：美國國家癌癥研究所Jnci雜志

主要研究方向：ONCOLOGY 非預(yù)警期刊審稿周期：

《美國國家癌癥研究所Jnci雜志》(Jnci-journal Of The National Cancer Institute)是一本由Oxford University Press出版的以O(shè)NCOLOGY為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽(yù)，影響因子不斷增加，發(fā)行量也同樣高。

1區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
183 年發(fā)文量
9.9 IF影響因子
未開放 是否OA
333 H-index
1940 創(chuàng)刊年份
Semimonthly 出版周期
English 出版語言

The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.

[ 查看全部 ]

投稿咨詢加急咨詢

Jnci-journal Of The National Cancer Institute期刊信息

ISSN：0027-8874
出版語言：English
是否OA：未開放
E-ISSN：1460-2105
出版地區(qū)：UNITED STATES
是否預(yù)警：否
出版商：Oxford University Press
出版周期：Semimonthly
創(chuàng)刊時(shí)間：1940
開源占比：0.2626
Gold OA文章占比：31.79%
OA被引用占比：0.2637...
出版國人文章占比：0.03
出版撤稿占比：0
研究類文章占比：94.54%

Jnci-journal Of The National Cancer Institute CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

4.986

2.556

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Oncology	Q1	28 / 404	93%
大類：Medicine 小類：Cancer Research	Q1	21 / 230	91%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Jnci-journal Of The National Cancer Institute中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	ONCOLOGY 腫瘤學(xué)	1區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	ONCOLOGY 腫瘤學(xué)	1區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	ONCOLOGY 腫瘤學(xué)	1區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	ONCOLOGY 腫瘤學(xué)	1區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	ONCOLOGY 腫瘤學(xué)	1區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	ONCOLOGY 腫瘤學(xué)	1區(qū)

Jnci-journal Of The National Cancer Institute JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ONCOLOGY	SCIE	Q1	28 / 322	91.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ONCOLOGY	SCIE	Q1	23 / 322	93.01%

Jnci-journal Of The National Cancer Institute歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Jnci-journal Of The National Cancer Institute中國學(xué)者發(fā)文選摘

1、DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer
Author: Yu, Huichuan; Wang, Xiaolin; Bai, Liangliang; Tang, Guannan; Carter, Kelly T.; Cui, Ji; Huang, Pinzhu; Liang, Li; Ding, Yanqing; Cai, Muyan; Huang, Meijin; Liu, Huanliang; Cao, Guangwen; Gallinger, Steven; Pai, Rish K.; Buchanan, Daniel D.; Win, Aung Ko; Newcomb, Polly A.; Wang, Jianping; Grady, William M.; Luo, Yanxin

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 1, pp. 52-61. DOI: 10.1093/jnci/djac183
2、Design and reporting of phase III oncology trials with prospective biomarker validation
Author: Liang, Fei; Peng, Ling; Wu, Zhengyu; Giamas, Georgios; Stebbing, Justin

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 174-180. DOI: 10.1093/jnci/djac210
3、Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts
Author: Hang, Dong; Wang, Lu; Fang, Zhe; Du, Mengxi; Wang, Kai; He, Xiaosheng; Khandpur, Neha; Rossato, Sinara L.; Wu, Kana; Hu, Zhibin; Shen, Hongbing; Ogino, Shuji; Chan, Andrew T.; Giovannucci, Edward L.; Zhang, Fang Fang; Song, Mingyang

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 155-164. DOI: 10.1093/jnci/djac221
4、Risk prediction models for endometrial cancer: development and validation in an international consortium
Author: Shi, Joy; Kraft, Peter; Rosner, Bernard A.; Benavente, Yolanda; Black, Amanda; Brinton, Louise A.; Chen, Chu; Clarke, Megan A.; Cook, Linda S.; Costas, Laura; Dal Maso, Luigino; Freudenheim, Jo L.; Frias-Gomez, Jon; Friedenreich, Christine M.; Garcia-Closas, Montserrat; Goodman, Marc T.; Johnson, Lisa; La Vecchia, Carlo; Levi, Fabio; Lissowska, Jolanta; Lu, Lingeng; McCann, Susan E.; Moysich, Kirsten B.; Negri, Eva; O'Connell, Kelli; Parazzini, Fabio; Petruzella, Stacey; Polesel, Jerry; Ponte, Jeanette; Rebbeck, Timothy R.; Reynolds, Peggy; Ricceri, Fulvio; Risch, Harvey A.; Sacerdote, Carlotta; Setiawan, Veronica W.; Shu, Xiao-Ou; Spurdle, Amanda B.; Trabert, Britton; Webb, Penelope M.; Wentzensen, Nicolas; Wilkens, Lynne R.; Xu, Wang Hong; Yang, Hannah P.; Yu, Herbert; Du, Mengmeng; De Vivo, Immaculata

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad014
5、Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions
Author: Lam, W. K. Jacky; King, Ann D.; Miller, Jacob A.; Liu, Zhiwei; Yu, Kelly J.; Chua, Melvin L. K.; Ma, Brigette B. Y.; Chen, Ming Yuan; Pinsky, Benjamin A.; Lou, Pei-Jen; Woo, John K. S.; Hsu, Wan-Lun; Simon, Julia; Doolan, Denise L.; Waterboer, Tim; Hui, Edwin P.; Li, Hui; Tsang, Raymond K.; Wong, Kenneth C. W.; Goh, Julian P.; Vlantis, Alexander C.; Ai, Qi Yong; Wong, Lun M.; Abdullah, Victor; Lin, Jin Ching; Chen, Chien-Jen; Pfeiffer, Ruth M.; Le, Quynh-Thu; Lee, Anne W. M.; Ji, Mingfang; Cao, Sumei; Ma, Jun; Chan, Anthony T. C.; Chan, K. C. Allen; Hildesheim, Allan

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 4, pp. 355-364. DOI: 10.1093/jnci/djad012
6、Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
Author: Spencer, Kristen; Pappas, Leontios; Baiev, Islam; Maurer, Jordan; Bocobo, Andrea Grace; Zhang, Karen; Jain, Apurva; De Armas, Anaemy Danner; Reyes, Stephanie; Le, Tri Minh; Rahma, Osama E.; Stanton, Jennifer; DeLeon, Thomas T.; Roth, Marc; Peters, Mary Linton B.; Zhu, Andrew X.; Lennerz, Jochen K.; Iafrate, A. John; Boyhen, Kylie; VanCott, Christine; Roberts, Lewis R.; Lindsey, Stacie; Horick, Nora; Goff, Laura Williams; Mody, Kabir; Borad, Mitesh J.; Shroff, Rachna T.; Kelley, Robin Kate; Javle, Milind M.; Goyal, Lipika

Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad046
7、Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
Author: Lambertini M¹, Campbell C², Bines J, Korde LA³, Izquierdo M⁴, Fumagalli D⁵, Del Mastro L⁶, Ignatiadis M¹, Pritchard K⁷, Wolff AC⁸, Jackisch C⁹, Lang I¹⁰, Untch M¹¹, Smith I¹², Boyle F¹³, Xu B¹⁴, Barrios CH¹⁵, Baselga J^16,¹⁷, Moreno-Aspitia A¹⁸, Piccart M¹, Gelber RD¹⁹, de Azambuja E¹.

Journal: J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094.
8、Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
Author: Schmit SL^1,², Edlund CK², Schumacher FR³, Gong J⁴, Harrison TA⁴, Huyghe JR⁴, Qu C^2,⁴, Melas M², Van Den Berg DJ², Wang H⁵, Tring S^2,^6,⁷, Plummer SJ⁸, Albanes D⁹, Alonso MH^10,^11,¹², Amos CI¹³, Anton K¹³, Aragaki AK⁴, Arndt V¹⁴, Barry EL¹⁵, Berndt SI⁹, Bezieau S⁴, Bien S¹⁶, Bloomer A¹, Boehm J¹⁷, Boutron-Ruault MC^18,¹⁹, Brenner H^14,^20,²¹, Brezina S²², Buchanan DD^23,^24,²⁵, Butterbach K¹⁴, Caan BJ²⁶, Campbell PT²⁷, Carlson CS⁴, Castelao JE²⁸, Chan AT^29,³⁰, Chang-Claude J^31,^32,³³, Chanock SJ⁹, Cheng I³⁴, Cheng YW³⁵, Chin LS³⁶, Church JM³⁷, Church T³⁸, Coetzee GA³⁹, Cotterchio M⁴⁰, Cruz Correa M⁴¹, Curtis KR⁴, Duggan D⁴², Easton DF⁴³, English D⁴⁴, Feskens EJM⁴⁵, Fischer R⁴⁶, FitzGerald LM^44,⁴⁷, Fortini BK⁴⁸, Fritsche LG^49,⁵⁰, Fuchs CS^51,⁵², Gago-Dominguez M^53,⁵⁴, Gala M²⁹, Gallinger SJ⁵⁵, Gauderman WJ², Giles GG^23,⁴⁴, Giovannucci EL^32,⁵⁶, Gogarten SM⁵⁷, Gonzalez-Villalpando C⁵⁸, Gonzalez-Villalpando EM⁵⁹, Grady WM⁶⁰, Greenson JK⁶¹, Gsur A⁶², Gunter M³⁰, Haiman CA², Hampe J⁶³, Harlid S⁶⁴, Harju JF⁴⁶, Hayes RB⁶⁵, Hofer P⁶², Hoffmeister M¹⁴, Hopper JL⁶⁶, Huang SC², Huerta JM⁶⁷, Hudson TJ^68,⁶⁹, Hunter DJ⁷⁰, Idos GE², Iwasaki M⁷¹, Jackson RD⁷², Jacobs EJ²⁷, Jee SH⁷³, Jenkins MA²³, Jia WH⁷⁴, Jiao S⁴, Joshi AD^30,⁷⁰, Kolonel LN⁷⁵, Kono S²², Kooperberg C⁴, Krogh V⁷⁶, Kuehn T⁷⁷, Küry S⁷⁸, LaCroix A⁴, Laurie CA⁵⁷, Lejbkowicz F¹, Lemire M⁶⁹, Lenz HJ^2,⁷⁹, Levine D⁵⁷, Li CI⁸⁰, Li L⁸¹, Lieb W⁸², Lin Y⁴, Lindor NM⁸³, Liu YR⁸⁴, Loupakis F³⁵, Lu Y⁸⁵, Luh F⁸⁶, Ma J⁸⁷, Mancao C⁸⁸, Manion FJ⁴⁶, Markowitz SD⁸⁹, Martin V⁹⁰, Matsuda K⁹¹, Matsuo K^92,⁹³, McDonnell KJ², McNeil CE², Milne R^23,⁴⁴, Molina AJ^11,⁹⁴, Mukherjee B⁴⁶, Murphy N⁹⁵, Newcomb PA⁴, Offit K⁹⁶, Omichessan H^18,¹⁹, Palli D⁹⁷, Cotoré JPP⁹⁸, Pérez-Mayoral J⁹⁹, Pharoah PD¹⁰⁰, Potter JD⁴, Qu C^2,⁴, Raskin L^85,⁹¹, Rennert G^86,^101,¹⁰², Rennert HS^86,¹⁰¹, Riggs BM¹, Schafmayer C¹⁰³, Schoen RE¹⁰⁴, Sellers TA¹, Seminara D¹⁰⁵, Severi G^18,¹⁰⁶, Shi W¹⁰⁷, Shibata D¹⁰⁸, Shu XO^85,⁹¹, Siegel EM¹, Slattery ML¹⁰⁹, Southey M²⁴, Stadler ZK^96,¹¹⁰, Stern MC², Stintzing S¹¹¹, Taverna D¹¹², Thibodeau SN¹¹³, Thomas DC², Trichopoulou A¹¹⁴, Tsugane S^2,^6,⁷, Ulrich CM¹⁷, van Duijnhoven FJB⁴⁵, van Guelpan B, Vijai J⁹⁶, Virtamo J¹¹⁵, Weinstein SJ⁹, White E⁴, Win AK²³, Wolk A¹¹⁶, Woods M¹¹⁷, Wu AH², Wu K¹¹⁸, Xiang YB¹¹⁹, Yen Y^35,¹²⁰, Zanke BW^121,¹²², Zeng YX⁷⁴, Zhang B¹²³, Zubair N⁴, Kweon SS^124,¹²⁵, Figueiredo JC^126,¹²⁷, Zheng W^85,⁹¹, Marchand LL⁵, Lindblom A¹²⁸, Moreno V^10,^11,¹², Peters U¹²⁹, Casey G⁸, Hsu L⁴, Conti DV², Gruber SB^2,⁷⁹.

Journal: J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.